Axler E, Lipner SR (2024) Antifungal selection for the treatment of onychomycosis: patient considerations and outcomes. Infect Drug Resist 17:819–843. https://doi.org/10.2147/idr.S431526
Article PubMed PubMed Central Google Scholar
Brito SCP, Pinto MR, Alcântara LM, Reis NF, Durães TL, Bittar CTM, de Oliveira JC, da Rocha EMS, Dantas Machado RL, Souza E Guimarães RJP, de Souza Baptista AR (2023) Spatio-temporal six-year retrospective study on dermatophytosis in Rio de Janeiro, Southeast Brazil: a tropical tourist locality tale. PLoS Negl Trop Dis 17(4):e0010865. https://doi.org/10.1371/journal.pntd.0010865
Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3(3):238–250. https://doi.org/10.1038/nrmicro1098
Article CAS PubMed Google Scholar
Choi H, Yang Z, Weisshaar JC (2015) Single-cell, real-time detection of oxidative stress induced in Escherichia coli by the antimicrobial peptide CM15. Proc Natl Acad Sci USA 112(3):E303–E310. https://doi.org/10.1073/pnas.1417703112
Article CAS PubMed PubMed Central Google Scholar
Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, Bromley M, Brüggemann R, Garber G, Cornely OA, Gurr SJ, Harrison TS, Kuijper E, Rhodes J, Sheppard DC, Warris A, White PL, Xu JP, Zwaan B, Verweij PE (2022) Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol 20(9):557–571. https://doi.org/10.1038/s41579-022-00720-1
Article CAS PubMed PubMed Central Google Scholar
Ghannoum MA, Long L, Kim HG, Cirino AJ, Miller AR, Mallefet P (2010) Efficacy of terbinafine compared to lanoconazole and luliconazole in the topical treatment of dermatophytosis in a Guinea pig model. Med Mycol 48(3):491–497. https://doi.org/10.3109/13693780903373811
Article CAS PubMed Google Scholar
Ghelardi E, Celandroni F, Gueye Sokhna A, Salvetti S, Senesi S, Bulgheroni A, Mailland F (2014) Potential of ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum. Antimicrob Agents Chemother 58(5):2825–2829. https://doi.org/10.1128/aac.02382-13
Article PubMed PubMed Central Google Scholar
Gold JAW, Benedict K, Lockhart S, Lutfy C, Lyman M, Smith D, Polgreen P, Beekmann S (2024) Recognition of antifungal-resistant dermatophytosis by infectious diseases specialists, United States. Emerg Infect Dis J 30(9):1978. https://doi.org/10.3201/eid3009.240118
Gregoriou S, Kyriazopoulou M, Tsiogka A, Rigopoulos D (2022) Novel and investigational treatments for onychomycosis. J Fungi 8(10):15. https://doi.org/10.3390/jof8101079
Huang Y, Huang J, Chen Y (2010) Alpha-helical cationic antimicrobial peptides: relationships of structure and function. Protein Cell 1(2):143–152. https://doi.org/10.1007/s13238-010-0004-3
Article CAS PubMed PubMed Central Google Scholar
Kobayashi D, Kondo K, Uehara N, Otokozawa S, Tsuji N, Yagihashi A, Watanabe N (2002) Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother 46(10):3113–3117. https://doi.org/10.1128/aac.46.10.3113-3117.2002
Article CAS PubMed PubMed Central Google Scholar
Koga H, Nanjoh Y, Kaneda H, Yamaguchi H, Tsuboi R (2012) Short-term therapy with luliconazole, a novel topical antifungal imidazole, in Guinea pig models of Tinea corporis and Tinea pedis. Antimicrob Agents Chemother 56(6):3138–3143. https://doi.org/10.1128/aac.05255-11
Article CAS PubMed PubMed Central Google Scholar
Lanternier F, Pathan S, Vincent QB, Liu L, Cypowyj S, Prando C, Migaud M, Taibi L, Ammar-Khodja A, Stambouli OB, Guellil B, Jacobs F, Goffard J-C, Schepers K, Marmol Vd, Boussofara L, Denguezli M, Larif M, Bachelez H, Michel L, Lefranc G, Hay R, Jouvion G, Chretien F, Fraitag S, Bougnoux M-E, Boudia M, Abel L, Lortholary O, Casanova J-L, Picard C, Grimbacher B, Puel A (2013) Deep dermatophytosis and inherited CARD9 deficiency. N Engl J Med 369(18):1704–1714. https://doi.org/10.1056/NEJMoa1208487
Article CAS PubMed PubMed Central Google Scholar
Lee HG, Bok E-Y, Jung Y-H, Hur T-Y, Kim Y-O, Kong HJ, Kim D-G, Kim Y-S, Oem JK (2024) Antifungal activity of aminopyrrolnitrin against trichophyton verrucosum in a Guinea pig model of dermatophytosis. Mycoses 67(5):e13748. https://doi.org/10.1111/myc.13748
Article CAS PubMed Google Scholar
Li R, Wang X, Yin K, Xu Q, Ren S, Wang X, Wang Z, Yi Y (2023) Fatty acid modification of antimicrobial peptide CGA-N9 and the combats against Candida albicans infection. Biochem Pharmacol 211:115535. https://doi.org/10.1016/j.bcp.2023.115535
Article CAS PubMed Google Scholar
Lima PG, Souza PFN, Freitas CDT, Bezerra LP, Neto NAS, Silva AFB, Oliveira JTA, Sousa DOB (2021) Synthetic peptides against trichophyton mentagrophytes and T. rubrum: mechanisms of action and efficiency compared to griseofulvin and itraconazole. Life Sci 265:118803. https://doi.org/10.1016/j.lfs.2020.118803
Article CAS PubMed Google Scholar
Lopes TDP, Souza PFN, da Costa HPS, Pereira ML, da Silva Neto JX, de Paula PC, Brilhante RSN, Oliveira JTA, Vasconcelos IM, Sousa DOB (2020) Mo-CBP4, a purified chitin-binding protein from Moringa oleifera seeds, is a potent antidermatophytic protein: in vitro mechanisms of action, in vivo effect against infection, and clinical application as a hydrogel for skin infection. Int J Biol Macromol 149:432–442. https://doi.org/10.1016/j.ijbiomac.2020.01.257
Article CAS PubMed Google Scholar
Mercer DK, Robertson JC, Miller L, Stewart CS, O’Neil DA (2020) NP213 (Novexatin®): a unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile. Med Mycol 58(8):1064–1072. https://doi.org/10.1093/mmy/myaa015
Article CAS PubMed PubMed Central Google Scholar
Mi YH, Zhong L, Lu SJ, Hu P, Pan Y, Ma XL, Yan BH, Wei ZH, Yang GM (2022) Quercetin promotes cutaneous wound healing in mice through Wnt/β-catenin signaling pathway. J Ethnopharmacol 290:13. https://doi.org/10.1016/j.jep.2022.115066
Migliolo L, Silva ON, Silva PA, Costa MP, Costa CR, Nolasco DO, Barbosa JARG, Silva MRR, Bemquerer MP, Lima LMP, Romanos MTV, Freitas SM, Magalhães BS, Franco OL (2012) Structural and functional characterization of a multifunctional alanine-rich peptide analogue from Pleuronectes americanus. PLoS ONE 7(10):e47047. https://doi.org/10.1371/journal.pone.0047047
Article CAS PubMed PubMed Central Google Scholar
Moreno MÁ, Ibrahim-Granet O, Vicentefranqueira R, Amich J, Ave P, Leal F, Latgé J-P, Calera JA (2007) The regulation of zinc homeostasis by the ZafA transcriptional activator is essential for Aspergillus fumigatus virulence. Mol Microbiol 64(5):1182–1197. https://doi.org/10.1111/j.1365-2958.2007.05726.x
Article CAS PubMed Google Scholar
Oliveira JTA, Souza PFN, Vasconcelos IM, Dias LP, Martins TF, Van Tilburg MF, Guedes MIF, Sousa DOB (2019) Mo-CBP3-PepI, Mo-CBP3-PepII, and Mo-CBP3-PepIII are synthetic antimicrobial peptides active against human pathogens by stimulating ROS generation and increasing plasma membrane permeability. Biochimie 157:10–21. https://doi.org/10.1016/j.biochi.2018.10.016
Article CAS PubMed Google Scholar
Osborne Colin S, Hofbauer B, Favre B, Ryder Neil S (2003) In vitro analysis of the ability of trichophyton rubrum to become resistant to terbinafine. Antimicrob Agents Chemother 47(11):3634–3636. https://doi.org/10.1128/aac.47.11.3634-3636.2003
Article CAS PubMed PubMed Central Google Scholar
Piraccini BM, Sisti A, Tosti A (2010) Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents. J Am Acad Dermatol 62(3):411–414. https://doi.org/10.1016/j.jaad.2009.04.062
Ryder NS (1992) Terbinafine: mode of action and properties of the squalene epoxidase Inhibition. Br J Dermatol 126(s39):2–7. https://doi.org/10.1111/j.1365-2133.1992.tb00001.x
Verma SB, Panda S, Nenoff P, Singal A, Rudramurthy SM, Uhrlass S, Das A, Bisherwal K, Shaw D, Vasani R (2021) The unprecedented epidemic-like scenario of dermatophytosis in India: I. Epidemiology, risk factors and clinical features. Indian J Dermatol Venereol Leprol 87(2):154–175. https://doi.org/10.25259/ijdvl_301_20
Weitzman I, Summerbell RC (1995) The dermatophytes. Clin Microbiol Rev 8(2):240–259. https://doi.org/10.1128/cmr.8.2.240
Comments (0)